A retrospective study assessing the utilization pattern of intravitreal anti-VEGF drug and dexamethasone in four Italian regions
Latest Information Update: 09 Oct 2020
Price :
$35 *
At a glance
- Drugs Aflibercept (Primary) ; Dexamethasone (Primary) ; Pegaptanib (Primary) ; Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 09 Oct 2020 New trial record